News | Health & Safety
24 Mar 2017 11:00
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     22 Mar: Spend on housing to prevent falls: study
     20 Mar: Medsafe probes use of Primodos in NZ
     19 Mar: Rural health pressure risks economy: RHA
     16 Mar: Too many kids given antibiotics by five
     16 Mar: Deaf Kiwis forced to wait for interpreters
     10 Mar: Salads recalled after listeria found
     09 Mar: Study backs school rheumatic fever clinics
     Top Stories

    RUGBY RUGBY
    Brumbies try to boost not so Super NZ run More...


    BUSINESS BUSINESS
    Struggling Intueri leaving Aust early More...



     Today's News

    Entertainment:
    Kate Hudson is reportedly dating musician Danny Fujikawa 10:49

    Politics:
    London attack: People return to Westminster Bridge to remember victims, stand for democracy 10:47

    Politics:
    Labour and Greens announce budget rules 10:47

    Business:
    Struggling Intueri leaving Aust early 10:27

    Entertainment:
    Kim Kardashian West is "still vulnerable" after her Paris robbery 10:19

    Business:
    Kiwi steady as Trump faces confidence test 10:07

    Entertainment:
    Ryan Reynolds has joked he’s in the “dog house” after he claimed Jake Gyllenhaal was a better cook than his wife 9:49

    Cricket:
    Trent Boult ruled out of third Test 9:27

    Entertainment:
    Robin Williams' widow Susan Schneider Williams wants her late husband's death to show other sufferers of dementia that they're not alone 9:19

    Law and Order:
    Shot in backside after salt 'drug' deal 8:57


     News Search






    Power Search


    © 2017 New Zealand City Ltd